Google-backed startup Isomorphic Labs, which uses AI for drug discovery, has raised $600 million in its first-ever external funding round led by Thrive Capital. The London-based startup was founded in 2021 as a spin-off from Alphabet's AI research subsidiary Google Deepmind. Isomorphic Labs said funds raised will be used to accelerate research and development as well as talent acquisition.